• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cyclacel Pharmaceuticals Inc

+ Add to Watchlist

CYCC:US

3.0900 USD 0.0400 1.28%

As of 20:10:00 ET on 09/15/2014.

Snapshot for Cyclacel Pharmaceuticals Inc (CYCC)

Open: 3.1000 Day's Range: 3.0600 - 3.1900 Volume: 101,891
Previous Close: 3.1300 52wk Range: 2.8800 - 5.5000 1-Yr Rtn: -8.58%

Stock Chart for CYCC

No chart data available.
  • CYCC:US 3.0800
  • 1D
  • 1M
  • 1Y
3.1300
Interactive CYCC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYCC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9800
Est. EPS (USD) (12/2014) -1.0100
Est. PEG Ratio -
Market Cap (M USD) 70.07
Shares Outstanding (M) 22.68
30 Day Average Volume 75,293
Price/Book (mrq) 2.3681
Price/Sale (ttm) 44.7068
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYCC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CYCC

Cyclacel Pharmaceuticals Inc. discovers and develops small molecule cycle inhibitors for the treatment of cancer and other serious diseases.

Spiro G RombotisPresident/CEOPaul McBarronExec VP:Finance/CFO/COO/Secy
Judy ChiaoVP:Clinical Dev & Reg Affairs
More Company Profile & Key Executives for CYCC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil